⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INO News
Inovio Pharmaceuticals, Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
accessnewswire.com
INO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
accessnewswire.com
INO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
accessnewswire.com
INO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
accessnewswire.com
INO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
accessnewswire.com
INO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
globenewswire.com
INO
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
prnewswire.com
INO
INOVIO Reports Inducement Grant Under Inducement Plan
prnewswire.com
INO
INOVIO to Participate in December Investor Conferences
prnewswire.com
INO
INOVIO Announces Pricing of $25 Million Public Offering
prnewswire.com
INO